ChromaDex Corporation and Subsidiaries | |||
Consolidated Statements of Operations | |||
Years Ended January 2, 2010 and January 3, 2009 | |||
2009 | 2008 | ||
Sales | $ 5,777,865 | $ 4,506,301 | |
Cost of sales | 3,736,435 | 3,274,800 | |
Gross profit | 2,041,430 | 1,231,501 | |
Operating expenses: | |||
Sales and marketing | 829,969 | 720,519 | |
General and administrative | 2,104,193 | 2,574,985 | |
2,934,162 | 3,295,504 | ||
Operating loss | (892,732) | (2,064,003) | |
Nonoperating (income) expenses: | |||
Interest expense | 17,090 | 70,079 | |
Interest income | (2,254) | (29,606) | |
14,836 | 40,473 | ||
Net loss | $ (907,568) | $ (2,104,476) | |
Basic and Diluted loss per common share | $ (0.03) | $ (0.07) | |
Basic and Diluted average common shares outstanding | 28,838,216 | 28,312,934 | |
See Notes to Consolidated Financial Statements. | |||